Life With Type 2: The Power of Naming

This is not a religious essay, so please don’t take the example below wrong. In Genesis, after God creates Adam, he tells him to go about naming the things that God has created-the animals, plants, and landscapes of the newly made world. Adam runs off, pleased to do God’s bidding, naming stuff right and left.Whether you believe in the creation story told by Genesis or

Read more

New Type 2 Drugs Change Treatment Decisions

Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of that population in 1997 to 53 percent in 2012. But that increase has since plateaued due to the introduction of additional drugs that target insulin secretion and glucose regulation. DPP-4 inhibitors, such as Januvia and Onglyza, now account for 21 percent of treatments. Long-acting insulins,

Read more

Life With Type 2: In Praise of Metformin

The fellow who writes one of the blogs I visit each morning often features links to articles about the wonders of bacon. Whenever he runs one of these items, showing yet another great thing about pork bellies, he asks, “Bacon: Is there anything it can’t do?” I often think the same thing about metformin, the inexpensive drug that is often the “starter” medicine for people

Read more

Metformin May Offer Defense Against Dementia in Type 2s

Not only can the diabetes drug metformin help control blood sugar levels, it may also reduce the risk of dementia, a health risk that’s elevated for those with diabetes. A recent study found that those taking metformin to help control blood glucose were 20 percent less likely to develop dementia over the course of the five-year study than those who were taking sulfonylureas to control

Read more

Common Diabetes Drugs May Carry Risk, Study Suggests

When it comes to the treatment of type 2 diabetes, metformin may be a safer choice than sulfonylureas, according to the results of a new study. In the study, conducted in Great Britain, people who used sulfonylureas as an initial way to control their blood glucose levels had a higher risk of death than those taking metformin. Sulfonylureas encourage increased production of insulin by the

Read more

Dapagliflozin Teams Well With Metformin, Sulfonylurea

According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea. The drug, already available in Europe, is produced by Bristol-Myers and AstraZeneca. It has been shown to improve blood sugar levels, help reduce body weight, and lead to lower A1c levels when used in tandem with the two other diabetes drugs. The

Read more

Metformin Boosts Survival in Men With Diabetes, Prostate Cancer

The drug of choice to treat type 2 diabetes may have uses beyond the treatment of diabetes alone, according to the results a new study. Researchers looked at data in which metformin was used to treat men who were suffering from both diabetes and prostate cancer, and found that the risk of mortality for those taking the drug during the first six months of treatment

Read more

Early Diabetes Interventions May Also Reduce Heart Disease Risk

Lifestyle change, medication both linked to cholesterol improvements Two treatments that slow the development of diabetes also may protect people from heart disease, according to a recent study published in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Researchers examined the effect that making intensive lifestyle changes or taking the medication metformin had on cholesterol and triglyceride levels. The study, part of the National

Read more

Metformin Better Than Insulin for Gestational Diabetes?

Insulin may not be the best first line of defense for women who develop gestational diabetes, according to the results of a new study. Research out of São Paulo, Brazil, suggests that for a majority of women who develop diabetes during pregnancy, metformin alone can lower blood glucose and neonatal hypoglycemia rates. During pregnancy, the same hormones that help the baby develop may cause insulin

Read more

Maryland Researchers Enrolling Type 2 Patients in Long-Term Drug Study

BALTIMORE-Researchers at the University of Maryland School of Medicine are enrolling patients with type 2 diabetes into an NIH-funded clinical trial to evaluate the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication. The University of Maryland Medical Center and the Baltimore VA Medical Center, which are affiliated with the University of Maryland School of

Read more